Examination Report |
1 | TM-1 | 20 Jan 2014 |
10 | Note Sheet | 11 Dec 2019 |
10 | Order | 11 Dec 2019 |
11 | TM-R(RENEWAL OF TRADE MARK) | 09 Jan 2024 |
2 | TM-16 | 27 Nov 2014 |
3 | Authorization Document (POA) | 27 Nov 2014 |
4 | TM-16 | 20 May 2015 |
5 | Reply to Exam Report (MIS-R) | 29 Feb 2016 |
6 | Journal Copy | 06 Mar 2017 |
7 | TM-O(NOTICE OF OPPOSITION) | 28 Jun 2017 |
8 | Certificate | 26 Nov 2019 |
9 | Note Sheet | 11 Dec 2019 |
9 | Order | 11 Dec 2019 |
1 | Dispatching of Examination Report for : 2662308 | 2812611 | 1424778 | 15 Jan 2016 |
2 | Opposition Notice | 5036074 | 2166976 | 14 Aug 2017 |
3 | Opposition Counter Statement | 5553995 | 2379669 | 13 Dec 2017 |
4 | Report Rule 45(2) Opposition | 9303577 | 26 Nov 2019 | |
5 | O3 NOTICE | 16301704 | 6299468 | 19 Oct 2023 |
6 | RENEWAL INTIMATION LETTER | 17131693 | 13 Jan 2024 |
The application for Xantin was made on 20 January 2014.
The trademark applicant for Xantin is SUN PHARMACEUTICAL INDUSTRIES.
Xantin is applied in class(es) 5.
Application for Xantin is on Registered stage.
Application Id allotted to Xantin is 2662308.
Xantin filed with the Intellectual property office as a WORD.